Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Illinois | Debridement & negative-pressure wound therapy · Ohio | |
|---|---|---|
| Surgeons, 2024 | 639 | 637 |
| Medicare fee-for-service cases | 135,945 | 116,086 |
| Growth since 2019 (Medicare FFS) | −2.4%/yr | −1.2%/yr |
| Forecast cases (Medicare FFS) | 136,300 in 2030 | 124,800 in 2030 |
| Forecast growth | 0%/yr to 2030 | +1.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 94.5 | 99.7 |
| Medicare Advantage share | 47% | 60% |
| Out of hospital | 44% (−5 pts since 2019) | 32% (−3 pts since 2019) |
| Cases per surgeon | 213 | 182 |
| Top 10 surgeons' share | 12% | 13% |
| Surgeons growing | 135 | 137 |
| New since the base year | 222 | 212 |
| Likely to stop billing it | 72 by 2026 | 86 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,135 | $1,083 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.